Long Term Follow-Up in Type 1 Diabetes Patients Using Continuous Subcutaneous Insulin Infusion Systems

被引：0
|
作者：
Saraiva, Joana
Carrilho, Francisco
Barros, Luisa
Batista, Carla
Melo, Miguel
Gomes, Leonor
Vieira, Alexandra
Alves, Marcia
Gouveia, Sofia
Moreno, Carolina
Carvalheiro, Manuela
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
913-P
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [41] Supporting patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Difficulties, disconnections, and disarray
    Perry, Lin
    James, Steven
    Gallagher, Robyn
    Dunbabin, Janet
    Steinbeck, Katharine
    Lowe, Julia
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2017, 23 (04) : 719 - 724
  • [42] Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
    Peter R van Dijk
    Susan JJ Logtenberg
    Klaas H Groenier
    Rijk OB Gans
    Nanne Kleefstra
    Henk JG Bilo
    BMC Endocrine Disorders, 14
  • [43] Type 1 Diabetes Patients Using Continuous Subcutaneous Insulin Infusion Therapy: Feeling Burdened Correlated with Factors
    Nishio, Ikuko
    Chujo, Masami
    YONAGO ACTA MEDICA, 2015, 58 (03) : 123 - 128
  • [44] Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
    van Dijk, Peter R.
    Logtenberg, Susan J. J.
    Groenier, Klaas H.
    Gans, Rijk O. B.
    Kleefstra, Nanne
    Bilo, Henk J. G.
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [45] IMPACT OF STRUCTURED CARE PROGRAM FOR INDIVIDUALS WITH TYPE 1 DIABETES USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN BRAZILIAN UNIFIED HEALTH SYSTEM: FOLLOW UP
    Flexa Ribeiro Filho, F.
    Santos, F.
    Ostuzzi, L. G. O.
    Cunha, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A169 - A170
  • [46] IMPACT OF STRUCTURED CARE PROGRAM FOR INDIVIDUALS WITH TYPE 1 DIABETES USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN BRAZILIAN UNIFIED HEALTH SYSTEM: FOLLOW UP
    Flexa Ribeiro Filho, F.
    Santos, F.
    Paes, L.
    Ostuzzi, L.
    Cunha, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A177 - A177
  • [47] Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion
    Noh, Yun-Hee
    Lee, Se-Myung
    Kim, Eun-Ju
    Lee, Hyunil
    Lee, Jun-Ho
    Lee, Ju-Han
    Park, So-Young
    Koo, Ja-Hyun
    Wang, Jun-Ho
    Lim, In-Ja
    Choi, Soo-Bong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (05) : 384 - 391
  • [48] A SINGLE INFUSION OF PROTRANS® MESENCHYMAL STROMAL CELL PRODUCT MAINTAINS ENDOGENOUS INSULIN PRODUCTION IN TYPE 1 DIABETES PATIENTS - A LONG TERM FOLLOW-UP STUDY
    Carlsson, P.
    Espes, D.
    Hill, H.
    Lundkvist, P.
    Davies, L. C.
    Sisay, S.
    Smith, C. E.
    Svahn, M.
    CYTOTHERAPY, 2023, 25 (06) : S50 - S50
  • [49] GLYCEMIC MANAGEMENT USING SIMPLE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 2 DIABETES
    Mader, J. K.
    Lilly, L. C.
    Warner, J. L.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A138 - A138
  • [50] Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: A follow-up report (vol 114, pg 1601, 2004)
    Weinzimer
    PEDIATRICS, 2005, 115 (02) : 518 - 518
12345